Apricus Biosciences (APRI) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Apricus Biosciences (APRI) Tops Q3 EPS by 1c

Apricus Biosciences Provides Corporate Update and Third Quarter 2015 Financial Results

November 5, 2015 4:01 PM EST

Company Continues to Advance Clinical Pipeline

Vitaros Quarterly Unit Sales Increased 146% in Europe

Conference Call / Webcast Today, Thursday, November 5, 2015 at 5:00 p.m. ET

SAN DIEGO, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today reported financial results for the third quarter and year to date ended September 30, 2015 and provided a corporate update on its clinical development plans for the remainder of 2015.

"The third quarter of this year was one of the... More